GlyNAC

    Fact-checked

    by:

    Last Updated: April 29, 2025

    GlyNAC is a term that describes co-administered glycine and N-acetylcysteine. The body of research on GlyNAC is small, but preliminary evidence shows promising effects for conditions with higher levels of oxidative stress, such as type 2 diabetes, HIV, and aging.

    Overview

    Dosage information

    The most common dosage in the (limited) body of research is 1.33 and 0.81 mmol/kg/day (millimoles per kilogram of bodyweight per day) of glycine and cysteine (in the form of N-acetylcysteine, which is about 74% cysteine), respectively. This dosage is equivalent to about 100 and 133 mg per kilogram of body weight per day (mg/kg/day) of glycine and N-acetylcysteine, respectively.

    Frequently asked questions

    Update History